The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity

scientific article published on 11 June 2013

The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BPC.2013.06.003
P698PubMed publication ID23820236
P5875ResearchGate publication ID244991285

P2093author name stringMassimo Stefani
Cristina Cecchi
P304page(s)30-43
P577publication date2013-06-11
P1433published inBiophysical ChemistryQ15760978
P1476titleThe amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity
P478volume182

Reverse relations

cites work (P2860)
Q42089651Amyloids, melanins and oxidative stress in melanomagenesis
Q41074727Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases
Q30374807Differential effects of glycation on protein aggregation and amyloid formation.
Q35793465Endocytosed 2-Microglobulin Amyloid Fibrils Induce Necrosis and Apoptosis of Rabbit Synovial Fibroblasts by Disrupting Endosomal/Lysosomal Membranes: A Novel Mechanism on the Cytotoxicity of Amyloid Fibrils
Q39221178Force spectroscopy reveals the presence of structurally modified dimers in transthyretin amyloid annular oligomers.
Q92070015Functional Amyloids and their Possible Influence on Alzheimer Disease
Q42828706Glycation of Wild-Type Apomyoglobin Induces Formation of Highly Cytotoxic Oligomeric Species
Q47647902Insights into protein misfolding and aggregation enabled by solid-state NMR spectroscopy.
Q40851188Interaction of toxic and non-toxic HypF-N oligomers with lipid bilayers investigated at high resolution with atomic force microscopy.
Q30402710Membrane remodeling by amyloidogenic and non-amyloidogenic proteins studied by EPR.
Q47330831Membrane-mediated amyloid deposition of human islet amyloid polypeptide
Q37622574Misfolded polyglutamine, polyalanine, and superoxide dismutase 1 aggregate via distinct pathways in the cell
Q47625995Molecular dynamics simulations of β2-microglobulin interaction with hydrophobic surfaces.
Q38771098Molecular pathogenesis of human amyloidosis: Lessons from β2 -microglobulin-related amyloidosis
Q39808570Non-Invasive Imaging of Amyloid Deposits in a Mouse Model of AGel Using (99m)Tc-Modified Nanobodies and SPECT/CT.
Q38798563Polyglutamine aggregates impair lipid membrane integrity and enhance lipid membrane rigidity
Q91730805Probing the Origin of the Toxicity of Oligomeric Aggregates of α-Synuclein with Antibodies
Q38497014Proteotoxicity and cardiac dysfunction
Q28082714Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases
Q34519909Sequestration of cellular interacting partners by protein aggregates: implication in a loss-of-function pathology
Q39338479The architecture of amyloid-like peptide fibrils revealed by X-ray scattering, diffraction and electron microscopy
Q38343014The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity
Q36327601Thermodynamic and fibril formation studies of full length immunoglobulin light chain AL-09 and its germline protein using scan rate dependent thermal unfolding
Q51730305Toxic HypF-N Oligomers Selectively Bind the Plasma Membrane to Impair Cell Adhesion Capability.
Q100750265Toxic oligomers of the amyloidogenic HypF-N protein form pores in mitochondrial membranes
Q35696876Two distinct β-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes
Q58691616d-Amino Acid Pseudopeptides as Potential Amyloid-Beta Aggregation Inhibitors

Search more.